JOSE PONTES JUNIOR

(Fonte: Lattes)
Índice h a partir de 2011
14
Lattes
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/55 - Laboratório de Urologia, Hospital das Clínicas, Faculdade de Medicina - Líder

Filtros

Limpar filtros

Configurações

Colaboração internacional: Chile ×

Resultados de Busca

Agora exibindo 1 - 2 de 2
  • article 1 Citação(ões) na Scopus
    Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
    (2021) LUZ, Murilo de Almeida; GUIMARAES, Gustavo Cardoso; NARDI, Aguinaldo Cesar; POMPEO, Alexandre Saad Feres Lima; SARKIS, Alvaro Sadek; NOWIER, Amr; POMPEO, Antonio Carlos Lima; JR, Archimedes Nardozza; JR, Ari Adamy; CARNEIRO, Arie; SALVAJOLI, Bernardo Peres; BENIGNO, Bruno Santos; JR, Celso Heitor de Freitas; CHADE, Daher Cezar; ANGOTTI, Clarissa; PALHARES, Daniel Moore Freitas; OTERO, Danilo Armando Citarella; SILVA NETO, Deusdedit Cortez Vieira da; CARVALHAL, Eduardo Franco; GIL, Erlon; ARRUDA, Fernando Freire de; KORKES, Fernando; LEMOS, Gustavo Caserta; CARVALHAL, Gustavo Franco; CARVALHO, Icaro Thiago de; GIMPEL, Ivan Federico Pinto; CHAMBO, Jose Luis; JR, Jose Pontes; RIBEIRO FILHO, Leopoldo Alves; NOGUEIRA, Lucas Mendes; WROCLAWSKI, Marcelo Langer; FREITAS, Marcelo Roberto Pereira; ARAP, Marco Antonio; SADI, Marcus Vinicius; BULBUL, Muhammad; COELHO, Rafael Ferreira; GADIA, Rafael; KHAULI, Raja B.; REIS, Rodolfo Borges Dos; ROJAS, Rodrigo Antonio Ledezma; GUIMARAES, Roger Guilherme; ALDOUSARI, Saad; FERRIGNO, Robson
    PURPOSE A group of international urology and medical oncology experts developed and completed a survey on prostate cancer (PCa) in developing countries. The results are reviewed and summarized, and recommendations on consensus statements for very low-, low-, and intermediate-risk PCa focused on developing countries were developed. METHODS A panel of experts developed more than 300 survey questions of which 66 questions concern the principal areas of interest of this paper: very low, low, and intermediate risk of PCa in developing countries. A larger panel of 99 international multidisciplinary cancer experts voted on these questions to create the recommendations for treatment and follow-up for very low-, low-, and intermediate-risk PCa in areas of limited resources discussed in this manuscript. RESULTS The panel voted publicly but anonymously on the predefined questions. Each question was deemed consensus if 75% or more of the full panel had selected a particular answer. These answers are based on panelist opinion not a literature review or meta-analysis. For questions that refer to an area of limited resources, the recommendations consider cost-effectiveness and the possible therapies with easier and greater access. Each question had five to seven relevant answers including two nonanswers. The results were tabulated in real time. CONCLUSION The voting results and recommendations presented in this document can be used by physicians to support management for very low, low, and intermediate risk of PCa in areas of limited resources. Individual clinical decision making should be supported by available data; however, as guidelines for treatment for very low, low, and intermediate risk of PCa in developing countries have not been developed, this document will serve as a point of reference when confronted with this disease.
  • article 3 Citação(ões) na Scopus
    Treatment of Localized and Locally Advanced, High-Risk Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries
    (2021) KHAULI, Raja; FERRIGNO, Robson; GUIMARAES, Gustavo; BULBULAN, Muhammad; USON JUNIOR, Pedro Luiz Serrano; SALVAJOLI, Bernardo; PALHARES, Daniel Moore Freitas; RACY, Douglas; GIL, Erlon; ARRUDA, Fernando Freire de; LEMOS, Gustavo Caserta; CARVALHAL, Gustavo Franco; CARVALHO, Icaro Thiago de; MARTINS, Igor Austin Fernandes; GIMPEL, Ivan Frederico Pinto; SALVAJOLI, Joao Victor; CHAMBO, Jose Luis; PONTES JUNIOR, Jose; RIBEIRO FILHO, Leopoldo Alves; NOGUEIRA, Lucas; FREITAS, Marcelo Roberto Pereira; WROCLAWSKI, Marcelo; ARAP, Marco Antonio; SADI, Marcus Vinicius; COELHO, Rafael; GADIA, Rafael; ROJA, Rodrigo Antonio Ledezma; HANRIOT, Rodrigo de Moraes; BARONI, Ronaldo; ZEQUI, Stenio; NAHAS, William Carlos; ALFER JUNIOR, Wladimir; MALUF, Fernando Cotait
    PURPOSE To generate and present survey results on important issues relevant to treatment and follow-up of localized and locally advanced, high-risk prostate cancer (PCa) focusing on developing countries. METHODS A panel of 99 PCa experts developed more than 300 survey questions of which 67 questions concern the main areas of interest of this article: treatment and follow-up of localized and locally advanced, high-risk PCa in developing countries. A larger panel of 99 international multidisciplinary cancer experts voted on these questions to create the recommendations for treatment and follow-up of localized and locally advanced, high-risk PCa in areas of limited resources discussed in this article. RESULTS The panel voted publicly but anonymously on the predefined questions. Each question was deemed consensus if 75% or more of the full panel had selected a particular answer. These answers are based on panelist opinion and not on a literature review or meta-analysis. For questions that refer to an area of limited resources, the recommendations considered cost-effectiveness as well as the possible therapies with easier and greater access. Each question had five to seven relevant answers including two nonanswers. Results were tabulated in real time. CONCLUSION The voting results and recommendations presented in this article can guide physicians managing localized and locally advanced, high-risk PCa in areas of limited resources. Individual clinical decision making should be supported by available data; however, as guidelines for treatment of localized and locally advanced, high-risk PCa in developing countries have not been defined, this article will serve as a point of reference when confronted with this disease.